MRNA vs. CCI
MRNA (Moderna, Inc.) and CCI (Crown Castle International Corp.) are both stocks. MRNA operates in Biotechnology (Healthcare), while CCI operates in REIT - Specialty (Real Estate). Over the past 5 years, MRNA returned -25.59%/yr vs -9.83%/yr for CCI. At a 0.16 correlation, their price movements are largely independent.
Performance
MRNA vs. CCI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRNA achieves a 69.24% return, which is significantly higher than CCI's 5.00% return.
MRNA
- 1D
- 0.54%
- 1M
- 1.77%
- YTD
- 69.24%
- 6M
- 69.42%
- 1Y
- 87.14%
- 3Y*
- -26.94%
- 5Y*
- -25.59%
- 10Y*
- —
CCI
- 1D
- 0.13%
- 1M
- 6.35%
- YTD
- 5.00%
- 6M
- 3.80%
- 1Y
- -2.96%
- 3Y*
- -2.02%
- 5Y*
- -9.83%
- 10Y*
- 4.09%
MRNA vs. CCI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
MRNA Moderna, Inc. | 69.24% | -29.08% | -58.19% | -44.63% | -29.28% | 143.11% | 434.10% | 28.09% | -30.59% |
CCI Crown Castle International Corp. | 5.00% | 2.96% | -16.39% | -10.24% | -32.57% | 35.08% | 15.49% | 35.45% | -6.62% |
Correlation
The correlation between MRNA and CCI is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Dec 7, 2018 | 0.16 |
Fundamentals
MRNA:
$19.71B
CCI:
$40.27B
MRNA:
-$8.16
CCI:
$2.42
MRNA:
8.78
CCI:
9.56
MRNA:
$2.23B
CCI:
$4.21B
MRNA:
-$309.00M
CCI:
$2.03B
MRNA:
-$3.02B
CCI:
$2.15B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRNA vs. CCI — Risk / Return Rank
MRNA
CCI
MRNA vs. CCI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Moderna, Inc. (MRNA) and Crown Castle International Corp. (CCI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRNA | CCI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.41 | ||
| Sortino ratioReturn per unit of downside risk | +2.12 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.00 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 2.34 | -0.12 | +2.45 |
| Martin ratioReturn relative to average drawdown | 4.59 | -0.20 | +4.78 |
Loading charts...
Drawdowns
MRNA vs. CCI - Drawdown Comparison
The maximum MRNA drawdown since its inception was -95.38%, roughly equal to the maximum CCI drawdown of -97.52%. Use the drawdown chart below to compare losses from any high point for MRNA and CCI.
Loading charts...
Drawdown Indicators
| MRNA | CCI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.38% | -97.52% | +2.14% |
Max Drawdown (1Y)Largest decline over 1 year | -35.51% | -30.01% | -5.50% |
Max Drawdown (3Y)Largest decline over 3 years | -86.58% | -30.77% | -55.81% |
Max Drawdown (5Y)Largest decline over 5 years | -95.38% | -55.48% | -39.90% |
Max Drawdown (10Y)Largest decline over 10 years | — | -55.48% | — |
Current DrawdownCurrent decline from peak | -89.70% | -45.30% | -44.40% |
Average DrawdownAverage peak-to-trough decline | -57.06% | -25.92% | -31.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.06% | 17.81% | +0.25% |
Volatility
MRNA vs. CCI - Volatility Comparison
Moderna, Inc. (MRNA) has a higher volatility of 17.56% compared to Crown Castle International Corp. (CCI) at 9.07%. This indicates that MRNA's price experiences larger fluctuations and is considered to be riskier than CCI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRNA | CCI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.56% | 9.07% | +8.49% |
Volatility (6M)Calculated over the trailing 6-month period | 48.82% | 22.61% | +26.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.75% | 26.97% | +37.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.49% | 26.63% | +39.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.15% | 25.99% | +46.16% |
Dividends
MRNA vs. CCI - Dividend Comparison
MRNA has not paid dividends to shareholders, while CCI's dividend yield for the trailing twelve months is around 4.61%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CCI Crown Castle International Corp. | 3.46% | 5.35% | 6.90% | 5.43% | 4.41% | 2.62% | 3.10% | 3.22% | 3.94% | 3.51% | 4.15% | 3.87% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MRNA vs. CCI - Financials Comparison
This section allows you to compare key financial metrics between Moderna, Inc. and Crown Castle International Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MRNA and CCI have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRNA has higher volatility (17.56%) compared to CCI (9.07%). In terms of maximum drawdown, MRNA dropped -95.38% vs CCI's -97.52%.
MRNA currently has the higher Sharpe Ratio (1.28 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRNA and CCI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer